Stemline Therapeutics Inc. (STML) Climbed 8.07% or 1.27 To Price $17.07 On Wednesday


Stemline Therapeutics Inc. (STML) climbed 8.07% or 1.27 to $17.07. It is about 193039 shares traded, which is 56.96% compare to the average total volume 338878. The market cap of STML is $431.77 million. The year to date change is 0.96%. The 52 week price range is from $6.35 to $17.4. Price of STML have changed 1.61% during last week. It have changed 10.88% over last month, 10.88% over last 3 months, 106.54% over last 6 months and 127.34% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for STML is 14.99. It is -12.19% below current price. The 200-day Moving Averages for STML is 11.36. It is -33.45% below current price. The 52-week High is 17.4. It is 1.93% from the current price. The 52-week Low is 6.35. It is -62.80% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of STML is 4.22 on 2018-01-31. Short % to float is 7.07%. There are some statistics of STML. It is has market cap $431.77 million. The share outstanding is 25.29 million. The average volume is 338878. The revenue is 1.20M. The percent of top 15 Institution holding is 59.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of STML is -83.11%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of STML is -70.44%.


Tags:

Share this post